Objective: High-frequency electroencephalography (EEG) activity has been observed in association with cognitive processing, including stimulus perception, consciousness and selective attention, in humans. The aim of this study was to compare visual-motor integrated processing between execution and inhibition of a motor response using event-related synchronization (ERS) and desynchronization (ERD) in the 15- to 80-Hz range and to investigate a relationship between event-related potentials (ERPs) and ERS/ERD in 10 normal young subjects. Methods: EEGs were recorded from 21 scalp sites during a visual go/no-go paradigm. For ERPs, 40 artifact-free trials were averaged off-line referenced to linked ear lobes. In the β and γ bands, ERS and ERD were calculated by time-frequency analysis. Results: Go N2 and no-go N2 were elicited 200-250 ms after stimuli, and their distributions were predominant at Fz. Go P3 was predominantly elicited 340-360 ms after stimuli at Pz, whereas no-go P3 was predominantly elicited 360-380 ms after stimuli at Cz. ERD of the β band at Fz and Cz during 300-600 ms showed in the go condition, whereas ERD showed between 39 and 42 Hz at F3 in the no-go condition. Conclusion: Oscillatory cortical response-related β and γ activities differ between the processing of execution and inhibition in motor responses. β ERDs in the sensorimotor areas with go stimuli may be related to motor responses, and γ ERDs in the left frontal area with no-go stimuli may be involved in the processing of inhibition of motor responses.
Our findings suggested that data from MPEG-2 images will lead to more precise diagnosis and treatment decision-making than data from analogue videotape recordings.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.